NHS Framework Agreement, Branded Medicines for London and South of England
Estimated value
—
goods
Awarded value
—
Suppliers
114
28 SME
Lots
6
114 awarded
Published
17 Sept 2021
Description
NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab.
Scope
- Reference
- ocds-h6vhtk-02ac57
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2021 to 31 Aug 2023
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- LondonUK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 114 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
BI
IP
BI
IP
AL
IP
UC
Lots · 6 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B. | — | cancelled |
| 4 | CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B. | — | cancelled |
| 2 | CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche. | — | cancelled |
| 3 | CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A. | — | cancelled |
| 6 | CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab | — | cancelled |